Dietary supplementation of exopolysaccharides from Lactobacillus rhamnosus GCC-3 improved the resistance of zebrafish against spring viremia of carp virus infection
Permanent link
https://hdl.handle.net/10037/27270Date
2022-08-05Type
Journal articleTidsskriftartikkel
Peer reviewed
Author
Xie, Mingxu; Li, Yu; Olsen, Rolf Erik; Ringø, Einar; Yang, Yalin; Zhang, Zhen; Ran, Chao; Zhou, ZhigangAbstract
Spring viremia of carp virus (SVCV) can cause high mortality of fish. The aim of
this study was to investigate the effects of Lactobacillus rhamnosus GCC-3
exopolysaccharides (GCC-3 EPS) on zebrafish (Danio rerio) infected with SVCV
and elucidate the underlying mechanisms. Zebrafish were fed with a control
diet or diet supplemented with 0.5% and 1% of GCC-3 EPS for 2 weeks. The
results showed that supplementation of GCC-3 EPS significantly improved the
survival rate of zebrafish compared with the control group. In addition, dietary
0.5% and 1% GCC-3 EPS significantly up-regulated the expression of genes
related to type I interferon (IFN) antiviral immunity. Consistent with in vivo
results, GCC-3 EPS significantly inhibited SVCV replication in zebrafish
embryonic fibroblast (ZF4) cells while significantly increased the expression
of type I IFN signaling pathway related genes. Furthermore, knocking down
TANK-binding kinase 1 significantly blocked the antiviral effect of GCC-3 EPS.
Dietary GCC-3 EPS improved gut microbiota, and the culture supernatant of
GCC-3 EPS-associated microbiota significantly inhibited SVCV replication in
ZF4 cells compared with the control-microbiota counterpart. In conclusion,
our results indicate that dietary GCC-3 EPS can improve the resistance of
zebrafish against SVCV infection, and the mechanism may involve enhanced
type I interferon signaling.
KEYWO
Publisher
Frontiers MediaCitation
Xie M, Li Y, Olsen RE, Ringø E, Yang Y, Zhang Z, Ran C, Zhou Z. Dietary supplementation of exopolysaccharides from Lactobacillus rhamnosus GCC-3 improved the resistance of zebrafish against spring viremia of carp virus infection. Frontiers in Immunology. 2022;13Metadata
Show full item recordCollections
Copyright 2022 The Author(s)